Skip to main content
. 2021 Mar 18;16(3):e0248642. doi: 10.1371/journal.pone.0248642

Fig 2. Resistance to different ARV drugs in children with virological failure.

Fig 2

The proportion of resistance to individual ARV drug is shown on the figure. Different ARV classes are indicated: NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibitors. ARV drugs are shown on the X-axis and the percentage of detection on the Y-axis. 3TC/FTC, lamivudine/emtricitadine; ZDV/AZT, zidovudine; DDI, didanosine; D4T, stavudine; ABC, abacavir; TDF, tenofovir; EFV, efavirenz; NVP, nevirapine; ETR, etravirine; RPV, rilpivirine; IDV, indinavir; SQV, saquinavir; NFV, nelfinavir; LPV, lopinavir; FPV, fosamprenavir; ATV, atazanavir; DRV, darunavir; TPV, tipranavir; r, ritonavir.